CareRx Corp's latest earnings report shows a significant underperformance, raising concerns among investors.
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$230.31M
P/E
8.6x
Div. yield
2.25%
Div. / share
$0.08
52W high
$3.95
52W low
$2.71
1W change
+7.08%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 41.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+41.7% Upside
Current Price
C$3.63
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
22.6%
Annualized
90-Day Vol
26.0%
Annualized
Trend (90d)
-3.5%
Annualized drift
90d Mean
C$3.59
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.62 | C$3.34 – C$3.91 |
| 60 trading days | C$3.60 | C$3.23 – C$4.02 |
| 90 trading days | C$3.59 | C$3.13 – C$4.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-02 | — | 0.0300 | — |
| 2026-06-30 | 2026-07-29 | 0.0100 | 0.0300 | -66.7% |
| 2026-03-31 | 2026-05-06 | 0.0200 | 0.0700 | -71.4% |
| 2025-12-31 | 2026-03-04 | 0.3700 | 0.0300 | +1133.3% |
| 2025-09-30 | 2025-11-03 | 0.0200 | 0.0300 | -33.3% |
| 2025-06-30 | 2025-07-30 | 0.0100 | 0.0100 | +0.0% |
Advertisement
CareRx Corp (CRRX.TO) released its fiscal Q2 2026 results after the market closed on July 29, 2026. The company reported earnings per share (EPS) of $0.01, which is below analyst expectations of $0.03. This 66.7% earnings miss highlights a notable shift from the previous quarter's performance and raises questions about the company’s effectiveness in the competitive health care sector.
Investor takeaway: Investors should keep a close eye on CareRx's ability to tackle operational challenges and improve its earnings moving forward. The significant EPS miss may lead to a reassessment of growth strategies and operational efficiencies.
EPS Misses by 66.7%
CareRx's EPS of $0.01 is a 66.7% miss from estimates, which is concerning given the company’s performance last quarter.
Bull case
Despite the recent earnings miss, CareRx has a strong track record of revenue growth and a solid position in the health care services sector. The company has a relatively low P/E ratio of 8.64, suggesting potential value for long-term investors. Additionally, CareRx has consistently paid dividends, showing its commitment to returning value to shareholders.
Bear case
The significant earnings miss and the downward revision of EPS consensus from $0.04 to $0.03 may indicate deeper operational issues. With only one earnings beat in the past four quarters, investor confidence could decline, leading to increased volatility in the stock price.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
